Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 12.12

Adjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,777 92.7% 0.5% 2,777 83.3% 0.7% 7,599 53.5% 0.8% 12,189 27.0% 0.8%
Lung Diagnosis Group Group A: Obstructive Lung Disease 989 94.4% 1.5% 989 86.6% 3.3% 3,151 47.7% 3.6% 5,706 19.8% 2.4%
Group B: Pulmonary Vascular Disease 115 86.8% 4.3% 115 82.1% 5.3% 311 53.4% 5.0% 541 37.7% 4.0%
Group C: Cystic Fibrosis or Immunodef. Disorders 372 94.8% 1.9% 372 82.9% 4.9% 1,101 44.5% 4.4% 1,808 27.8% 3.2%
Group D: Restrictive Lung Disease 1,232 91.4% 2.4% 1,232 80.4% 4.9% 2,861 60.8% 3.5% 3,825 33.1% 3.4%
Group E: Age Less Than 12 25 87.4% 9.8% 25 75.5% 14.3% 93 43.0% 8.9% 178 36.2% 6.4%
Other Diagnosis 44 92.8% 3.8% 44 91.0% 4.4% 82 62.5% 8.2% 131 38.7% 7.3%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.